Biomerieux analyzer, reagents, supplies and services for mamc.

Ended Purchase Order Awarded Last action

Contract number
W81K0223P0128
Awardee
Awarding agency
Obligated
$534,008

Award facts

Opportunity
Contract value 100% obligated
$534,007.98 Current and potential, with all options
Completion date 100% complete
  • Current, with exercised options
  • Potential, with all options
Set-aside
No set-aside
Competition
Not Competed · 1 offer Only One Source
Pricing
Firm Fixed Price
Place of performance
LEWIS MCCHORD, WA 98431, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action P00008 · Nucleic acid extraction analyzer $0
Other Administrative Action P00007 · DHA transfer $0
Supplemental Agreement for work within scope P00006 -$96,770
Funding Only Action P00005 · Modification to add FY25 funding for OY 4, 10/1/24 - 9/30/25 $295,458
Exercise an Option P00004 · Modification to exercise option year 1, 1 OCT 2024 - 30 SEP 2025. $0
Supplemental Agreement for work within scope P00003 · Modification to add AST cards, adds service/maintenance for virtuo and changes analyzer from purchase to lease. -$38,330
Funding Only Action P00002 · Modification to add FY24 funds to the base year (1 october 2023 - 30 september 2024. $373,650
Other Administrative Action P00001 · Biomerieux analyzer, reagents, supplies, and services for mamc. Modification to SOW. $0
Original award $0

About this award

Written by GovTribe AI ·

The Defense Health Agency awarded a purchase order to Biomerieux Inc. for biomerieux analyzer, reagents, supplies, and services for Madigan Army Medical Center with a ceiling value of $534,007.98, awarded October 1, 2023. Performance occurs at Lewis-McChord, Washington. The order procures nucleic acid extraction analyzer equipment, associated reagents, and supplies on a firm fixed-price basis with an ultimate completion date of September 30, 2025. The requirement originated from a pre-solicitation capability statement opportunity posted April 27, 2023 (due date July 27, 2023) that sought pathology laboratory testing equipment including reagents, maintenance, training, and supplies for nucleic acid extraction, liquid media blood culture, mass spectrometry, and automated identification and susceptibility systems interfacing with MHS Genesis and Myla middleware.

Quick answers

Who was awarded contract W81K0223P0128?

W81K0223P0128 was awarded to Biomerieux Inc. by Defense Health Agency (Department of Defense) on October 1, 2023.

How much is contract W81K0223P0128 worth?

The government has obligated $534,008 on W81K0223P0128.

Was contract W81K0223P0128 competed?

The extent of competition for W81K0223P0128 was not competed. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login